
Share
OpenAI is contemplating a radical shift that could unleash its AGI technology for commercial purposes, potentially reshaping the competitive landscape and partnership dynamics within the AI industry.
In a move that could have far-reaching implications for the future of artificial intelligence, OpenAI is reportedly considering dropping a provision that would prevent its most advanced technology-artificial general intelligence (AGI)-from being used for commercial gain. According to a report by the Financial Times, this decision could significantly impact Microsoft, one of OpenAI’s major partners and investors.
Artificial General Intelligence (AGI) represents a significant leap from current AI systems. Unlike today's narrow AIs, which excel in specific tasks like language processing or image recognition, AGI would be capable of performing a wide range of complex tasks with human-like autonomy and intelligence. The potential benefits are immense, ranging from healthcare advancements to more efficient business operations. However, the risks are equally significant, including job displacement, privacy concerns, and ethical dilemmas.
The provision in question is part of OpenAI's broader governance framework, designed to ensure that AGI is developed and used responsibly. Specifically, it would prevent any single entity from monopolizing the commercial benefits of AGI. This means that even Microsoft, which has invested heavily in OpenAI, would not have exclusive rights to commercialize AGI once it is achieved.
The decision to potentially drop this provision has sparked a heated debate among policymakers, ethicists, and industry leaders. Proponents argue that allowing commercial use could accelerate innovation and bring the benefits of AGI to market more quickly. For example, pharmaceutical companies could use AGI to develop new drugs faster, or tech firms could create more advanced AI-powered tools for consumers.
On the other hand, critics warn that unrestricted commercialization could exacerbate existing inequalities and lead to a concentration of power in the hands of a few large corporations. They point out that without proper safeguards, AGI could be used in ways that harm society, such as automating jobs on a massive scale or enabling new forms of surveillance.

Microsoft's stake in this decision is significant. As one of OpenAI’s primary investors and partners, the tech giant stands to gain substantial benefits from commercializing AGI. However, if the provision remains in place, Microsoft would be limited in how it can use and profit from AGI. This raises questions about whether the company's interests are aligning with broader societal goals.
The potential changes at OpenAI highlight the need for robust regulatory frameworks to govern the development and deployment of AGI. Policymakers must balance the benefits of innovation with the risks of unchecked commercialization. Some possible policy measures include:
As OpenAI weighs its options, the broader AI community is closely watching. The decision could set a precedent for how other organizations approach the commercialization of advanced AI technologies. It also underscores the importance of ongoing dialogue between tech companies, policymakers, and the public to ensure that AGI is developed in a way that aligns with societal values.
The potential removal of the provision to prevent commercial use of AGI by OpenAI highlights the complex interplay between innovation, ethics, and regulation. As we stand on the brink of this technological frontier, it is crucial that we proceed with caution, guided by a commitment to responsible development and equitable access.
Tags
Original Sources
About the author
Amara's entry point into AI was an epidemiology role at a London research hospital, where she spent five years studying how digital health tools reached — or conspicuously failed to reach — underserved communities. Watching early algorithmic systems in healthcare quietly entrench existing inequalities, she redirected her career toward the systemic consequences of AI at scale. She covers AI through an unflinching lens: who benefits, who bears the cost, and what evidence actually says versus what the press release claims. Her writing is calm and precise, but she doesn't mistake balance for neutrality.
More from The Steward →This Week's Edition
13 December 2024
88 articles
Related Articles
Related Articles
More Stories